| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 430,100 | 991,000 | 680,600 | 1,072,000 | | Cost of Revenue | 306,100 | 564,000 | 518,300 | 711,300 | | | Gross Profit | 124,000 | 427,000 | 162,300 | 360,700 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 34,200 | 31,800 | 38,600 | 12,300 | | Non Recurring |
-
|
-
|
-
| 4,500 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 89,800 | 395,200 | 123,700 | 343,900 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,100 | 800 | 1,600 | 3,600 | | Earnings Before Interest And Taxes | 91,900 | 396,000 | 125,300 | 297,700 | | Interest Expense | 400 | 300 | 400 | 400 | | Income Before Tax | 91,500 | 395,700 | 124,900 | 297,300 | | Income Tax Expense | 32,100 | 146,800 | 41,200 | 103,900 | | Minority Interest | (77,000) |
-
|
-
| (49,800) | | | | Net Income From Continuing Ops | (17,000) | 248,200 | 83,000 | 190,100 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (17,000) | 248,200 | 83,000 | 190,100 | | Preferred Stock And Other Adjustments | 55,500 | (35,200) | (20,300) |
-
| | | Net Income Applicable To Common Shares | $38,500 | $213,000 | $62,700 | $190,100 |
|
0.31% Nasdaq 
0.05%
Income Statement
